Sector pending / General Medical and Surgical HospitalsUpdated 2026-05-10 22:07 UTC

FRA/02M1 stock hub

FRA/02M1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/02M1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.2B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/02M1FRA/02M1

—

Loading chart…

In the news

Latest news · FRA/02M1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.4

P25 n/aP50 n/aP75 n/a

Trailing P/E26.4

P25 n/aP50 n/aP75 n/a

ROE6.7

P25 n/aP50 n/aP75 n/a

ROIC7.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/02M1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

213

Groups with data

Currency

SGD

Showing 213 of 213 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Singapore
Country code	DE
Employees	2,965
Employees Change	-24%
Employees Change Percent	-0.8
Enterprise value	EUR 1.1B
Exchange	Frankfurt Stock Exchange
Financial currency	SGD
First seen	2026-05-10
Industry	General Medical and Surgical Hospitals
Last refreshed	2026-05-10
Market cap	EUR 1.2B
Price	EUR 0.66
Price currency	EUR
Rev Per Employee	170,972.38x
Sic	8062
Symbol	fra/02M1
Website	https://www.rafflesmedicalgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.79%
EV Earnings	23.16x
EV/EBIT	18.78x
EV/EBITDA	12.59x
EV/FCF	17.49x
EV/Sales	2.11x
FCF yield	5.02%
Forward P/E	25.4x
P/B ratio	1.76x
P/E ratio	26.4x
P/S ratio	2.43x
PE Ratio10 Y	24.76x
PE Ratio3 Y	27.48x
PE Ratio5 Y	26.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	11.23%
EBITDA Margin	15.25%
FCF margin	12.21%
Gross margin	45.37%
Gross Profit	EUR 230M
Gross Profit Growth	-0.38%
Gross Profit Growth Q	-0.76%
Gross Profit Growth3 Y	3.76%
Gross Profit Growth5 Y	-4.31%
Net Income	EUR 46.7M
Net Income Growth	13.38%
Net Income Growth Q	21.72%
Net Income Growth3 Y	5.01%
Net Income Growth5 Y	-13.24%
Pretax Margin	12.23%
Profit Margin	9.22%
Profit Per Employee	EUR 15,760
ROA	3.68
Roa5y	5.06
ROCE	7.84
ROE	6.7
Roe5y	8.91
ROIC	7.84
Roic5y	10.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-1.49%
Cagr3y	-9.72%
EPS Growth	14.07
EPS Growth Q	22.45
EPS Growth3 Y	5.56
EPS Growth5 Y	-13.08
FCF Growth	39.53%
FCF Growth Q	-9.95%
FCF Growth3 Y	7.87%
FCF Growth5 Y	-10.77%
OCF Growth	17.48%
OCF Growth Q	-13.46%
OCF Growth10 Y	-2.69%
OCF Growth3 Y	1.4%
OCF Growth5 Y	-11.63%
Revenue Growth	1.75x
Revenue Growth Q	0.1x
Revenue Growth3 Y	2.88x
Revenue Growth5 Y	-0.52x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.52
Assets	EUR 946.9M
Cash	EUR 205.8M
Current Assets	EUR 291.6M
Current Liabilities	EUR 223.2M
Debt	EUR 57.9M
Debt EBITDA	EUR 0.68
Debt Equity	EUR 0.08
Debt FCF	EUR 0.94
Equity	EUR 699.2M
Interest Coverage	20.99
Liabilities	EUR 247.6M
Long Term Assets	EUR 655.3M
Long Term Liabilities	EUR 24.4M
Net Cash	EUR 147.9M
Net Cash By Market Cap	EUR 11.99
Net Cash Growth	-12.58%
Net Debt EBITDA	EUR -1.91
Net Debt Equity	EUR -0.21
Net Debt FCF	EUR -2.39
Tangible Book Value	EUR 691.7M
Tangible Book Value Per Share	EUR 0.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.31
Inventory Turnover	37.98
Net Working Capital	EUR -98.4M
Quick ratio	1.27
Working Capital	EUR 67.7M
Working Capital Turnover	EUR 4.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.36%
Dividend Growth	4.74%
Dividend Growth Years	1%
Dividend per share	EUR 0.02
Dividend Years	3
Dividend Yield	2.63%
Ex Div Date	2025-05-13
Last Dividend	EUR 0.02
Payout Frequency	Annual
Payout Ratio	65.57%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-1.49%
200-day SMA	0.64
3Y total return	-26.42%
50-day SMA	0.66
50-day SMA vs 200-day SMA	50over200
All Time High	1.04
All Time High Change	-37.02%
All Time High Date	2023-05-04
All Time Low	0.56
All Time Low Change	18.02%
All Time Low Date	2024-12-19
ATR	0
Ch YTD	3.15
High	0.66
High52	0.87
High52 Date	2025-08-15
High52ch	-24.71%
Low	0.66
Low52	0.61
Low52 Date	2025-06-25
Low52ch	8.26%
Ma50ch	-0.35%
Price vs 200-day SMA	1.99%
RSI	44.8
RSI Monthly	43.03
RSI Weekly	53.05
Sharpe ratio	0.15x
Sortino ratio	0.39
Total Return	2.99%
Tr YTD	3.15
Tr1m	-2.24%
Tr3m	3.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 56.9M
Operating Income Growth	0.65
Operating Income Growth Q	1.24
Operating Income Growth3 Y	5.67
Operating Income Growth5 Y	-15.84
Operating margin	11.23

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	771,975,534%
Net Borrowing	-30,199,571.5
Shares Insiders	15.54%
Shares Institutions	12.02%
Shares Qo Q	-0.31%
Shares Yo Y	-0.36%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 59.9M
Average Volume	0x
Bv Per Share	0.38
CAPEX	EUR -5.2M
Ch1m	-2.24
Ch1y	-3.68
Ch3m	3.97
Ch3y	-31.77
Ch6m	3.97
Change	-0.76%
Change From Open	0
Close	0.66
Days Gap	-0.76
Depreciation Amortization	20,590,495.2
Earnings Date	2026-07-28
EBIT	EUR 56.9M
EBITDA	EUR 77.3M
EPS	EUR 0.03
F Score	6
FCF	EUR 61.9M
FCF EV Yield	5.72x
Financing CF	-86,641,999
Fiscal Year End	December
Founded	1,976
Goodwill	5,184,926.6
Graham Number	0.45521
Graham Upside	-30.5
Income Tax	EUR 14.9M
Investing CF	-1,658,730
Is Primary Listing	0
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Lynch Fair Value	EUR 0.12
Lynch Upside	-81.06
Ma150	0.64
Ma150ch	2.33%
Ma20	0.66
Ma20ch	-1.1%
Net CF	-21,772,075
Next Earnings Date	2026-07-28
Open	0.66
P FCF Ratio	19.93
P OCF Ratio	18.39
Payment Date	2025-05-23
Ppne	496,075,501.4
Price Date	2026-05-08
Price EBITDA	EUR 15.96
Ptbv Ratio	1.78
Relative Volume	2,000x
Revenue	506,933,100x
SBC By Revenue	0.4x
Share Based Comp	2,030,206
Tax By Revenue	2.94x
Tax Rate	24.06%
Tr6m	3.97%
Z Score	4.33

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/02M1 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.6%

$0.02 annual per share

Payout ratio

+65.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+3.0%

Next ex-dividend date: 2025-05-13

Performance

FRA/02M1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/02M1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+12.0%

Share of float held by funds and institutions

Insider ownership

+15.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.4%

Negative means the company is buying back shares.

Technical

FRA/02M1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.8

Neutral momentum band

Price vs 200-day MA

+2.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/02M1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/02M1 stock rating?

fra/02M1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/02M1 analysis?

The full report lives at /stocks/fra/02M1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/02M1?

The latest report frames fra/02M1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/02M1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.